TransCon CNP

C-type natriuretic peptide prodrug · Ascendis Pharma A/S

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for TransCon CNP, covering 2023-11-02 to 2026-07-14. Get the full timeline:

Most recent: Clinical Trial Results: A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Children With Achondroplasia [Phase 2, Phase 3]

See pricing